Women race, age and regional US & non-US subgroup analysis of dolutegravir (DTG) and non-integrase inhibitor treatment (non-INSTI) regimens in naïve randomized clinical trials at Week 48.

Topics

R. Quercia Reviews in Antiviral Therapy & Infectious Diseases 1, 2020